About Company

OMNINOME

We are a multidisciplinary team of physician-geneticists, molecular biologists, and bioinformaticians dedicated to precision medicine. Founders Irina Zhegulina, MD, and Denis Gudkov, PhD, united clinical genetic expertise and computational research to make whole-genome and whole-exome data directly actionable in healthcare. For over 15 years, our team has pioneered genomic methodologies empowering clinicians and patients to make evidence-based medical decisions.

Our Mission

To make precision genomic diagnostics an accessible, intuitive, and indispensable tool for every physician and patient. We believe that deep genomic intelligence enables longer, healthier, and more empowered lives.

Our Vision

To lead the global standard for clinical pharmacogenomics and whole-exome diagnostics. We envision genomic insights integrated seamlessly into routine patient care, preventing adverse drug reactions and accelerating early clinical detection worldwide.

Our Values

Scientific Integrity

Every conclusion is rooted in evidence-based medicine and peer-reviewed studies. We transparently report variant classifications, confidence metrics, and methodological bounds.

Accessibility & Clarity

We believe precision genomics should be democratized. Our pricing is straightforward and reports are crafted to be directly interpretable by clinicians and patients alike.

Omninome Team
Omninome Laboratory

Continuous Innovation

We continually iterate our computational algorithms, database curations, and analytical workflows based on emerging breakthroughs in molecular biology.

Clinical Quality

Our partner sequencing laboratories operate under rigorous international quality control standards, employing state-of-the-art NGS platforms and bioinformatics QC.

Omninome achievements

Our Achievements

Our Team

Photo: Irina Zhegulina, MD
Irina Zhegulina, MD
Co-Founder, Clinical Geneticist

Co-founder of Omninome. Directs medical methodology and clinical product translation. Renowned expert in clinical genomics, oncogenetics, and translating complex multi-gene panels into actionable patient care.

Clinical GeneticsOncogeneticsPrecision Medicine
Photo: Denis Gudkov, PhD
Denis Gudkov, PhD
Co-Founder, Biologist, PhD in Chemical Sciences

Co-founder of Omninome. Leads scientific R&D, laboratory strategy, and translational partnerships. Operates at the intersection of molecular biology, high-throughput data science, and product development.

Molecular BiologyTranslational R&DProduct Strategy
Photo: Dmitry Osipenko
Dmitry Osipenko
Lead Bioinformatician

Architects and maintains automated NGS bioinformatics pipelines. Ensures rigorous quality control, variant classification reproducibility, and high-performance exome calling.

BioinformaticsGenomic AnalysisVariant InterpretationAI/ML
Photo: Antonina Akimenko
Antonina Akimenko
Senior Medical Analyst

Oversees clinical knowledge base curation, variant validation algorithms, and report synthesis, optimizing evidence translation for clinical utility.

Clinical InterpretationData QualityMedical Reporting

Expert Clinical Team

Specialists in Medical Genetics & Clinical Bioinformatics

Our team merges clinical care and computational genomics to make genetic intelligence actionable in real-world medicine. We collaborate with leading hospitals and academic research institutions globally.

PhysiciansGeneticistsBioinformaticiansScientific Advisors

Scientific Advisory Board

Consultants & Academic Experts

We collaborate with prominent researchers in pharmacogenomics, molecular diagnostics, and individualized medicine from top medical centers and universities.

PharmacogenomicsBioinformaticsClinical GuidelinesResearch Collaboration

Company Milestones

2023
Founding of Omninome Inc.
2025
Launch of Whole Exome Sequencing panel
2025
Launch of Clinical Pharmacogenomics platform
2026
Launch of Gut Microbiota Metagenomic analysis
2026
Launch of Anesthesia Genetic Risk panel
2026
Launch of Digital Portal & AI Genetic Assistant Nome
Omninome collaboration icon

Partner with Omninome

If you are a physician, hospital, clinic, or research partner interested in integrating our genomic panels,
get in touch with our clinical team.